MPR Weekly Dose 194 — OTC Birth Control Pill; First OTC Continuous Glucose Monitor; Influenza Vaccine for 2024/2025 Season; Breakthrough Therapy for LSD; Biosimilars to Prolia and Xgeva
MPR Weekly Dose8 Mar 2024

MPR Weekly Dose 194 — OTC Birth Control Pill; First OTC Continuous Glucose Monitor; Influenza Vaccine for 2024/2025 Season; Breakthrough Therapy for LSD; Biosimilars to Prolia and Xgeva

Over-the-counter birth control pill to be available in the coming weeks; first over-the-counter continuous glucose monitor to be available starting this summer; the 2024-2025 US influenza season vaccine will be trivalent; LSD granted Breakthrough Therapy for treatment of generalized anxiety disorder; interchangeable biosimilars to Prolia and Xgeva approved.

Episoder(266)

MPR Weekly Dose Podcast: Episode 2

MPR Weekly Dose Podcast: Episode 2

This week: New draft guidelines for Lyme Disease management; First-in-class antibiotic to treat community-acquired bacterial pneumonia; Duchenne muscular dystrophy drug denied; Approval for a rheumato...

23 Aug 20195min

MPR Weekly Dose Podcast: Episode 1

MPR Weekly Dose Podcast: Episode 1

This week the team discuss the 'Cure All' treatments that contain bleach, news concerning a Parkinson disease treatment, a new approval for a tuberculosis treatment, differences between the US and Can...

19 Aug 20197min

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
rss-garne-damer
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
morten-ramm-lar-kakla-ga-til-du-sovner
foreldreradet
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
rss-lopedrommen
klimaks
rss-sunn-okonomi
hormonelle-frida
hjernesterk
g-punktet
helsetipspodden
sinnsyn
rss-kunsten-a-leve